Paydirt
SE
Insider

Sravan Kumar Emany

Chief Financial Officer

Sravan Kumar Emany (Chief Financial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Beam Therapeutics Inc. (BEAM). The largest single filing was $171K of BEAM (6,294 sh × $27.10, as filed), executed Dec 31 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$171K
shares × price, as filed
Last traded
Dec 31 2025
Filed Jan 5

Median ADV $56.9M across their filed names

Open performance
Volume by month
$171K$85K$0Oct 2024Apr 2025Oct 2025Apr 2026Jan 2026 · sells $171K
Buys $0 Sells $171K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
BEAM Beam Therapeutics Inc. BEAM · 0 buys · 1 sell 1 filing
Recent filings
BEAMSALE Beam Therapeutics Inc. View filing → $171K
6,294 sh × $27.10
Exec Dec 31 2025
Filed Jan 5 · 5:30 PM ET